Cite
HARVARD Citation
Raimondi, A. et al. (n.d.). PD-016Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study. Annals of oncology. p. . [Online].